Navigation Links
Ajinomoto Co.'s Capsiate Natura® Reaches New Milestone
Date:3/7/2011

FORT LEE, N.J., March 7, 2011 /PRNewswire/ -- Ajinomoto Co., a leader in the development of pharmaceutical-quality amino acids and safe, effective nutraceutical solutions, has announced that its patented dietary supplement Capsiate Natura® has been granted federal trademark registration, (®), on the Principal Register of the United States Patent and Trademark Office.  The trademark is the latest milestone for Capsiate Natura®, the first and only dietary supplement with natural capsinoids extracted from the CH-19 Sweet pepper.  Extensively researched in the US and Japan, Capsiate Natura® has been shown to boost the body's metabolism* without a burning sensation and other side-effect concerns.

"While most weight management aids focus on the caloric intake, Capsiate Natura® is unique in targeting the other side of the equation, the caloric output," said Brendan Naulty, president of Ajinomoto Food Ingredients.  "Increasing the body's metabolism to burn more calories can be as important to weight management as diet and exercise."  

The CH-19 Sweet pepper, a non-pungent variety of pepper discovered by Japanese plant biologists and grown by Ajinomoto Co. exclusively in Thailand, is the unique source of capsinoids, the key ingredient in Capsiate Natura®.   Ten thousand pounds of CH-19 Sweet pepper yield just one pound of capsinoids which, unlike regular hot pepper extracts, are non-burning to the stomach and are safe partly because of no cardiovascular side effects, which is very important in therapeutic use.   Capsinoids' safety and efficacy have been researched in nearly 50 extensive studies conducted in Japan, Europe and US to date.

First introduced in the US in 2007, Capsiate Natura® is available exclusively through medical professionals.  Today, over 200 doctors are distributing the product and recommending it to their patients as a unique addition to their weight management regimen.  The network of doctors includes over 100 physicians affiliated with The Center for Medical Weight Loss (www.centerformedicalweightloss.com).

"Capsiate Natura® delivers the thermogenic punch of capsaicin without the pungency or any adverse effects," said Dr. Michael Kaplan, a founder and Chief Medical Officer of The Center for Medical Weight Loss.  "I consistently recommend it to patients who prefer a natural approach in conjunction with our own program or want to jumpstart their metabolism to avoid the natural slowing or plateau that often occurs in weight management."

Capsiate Natura® has successfully completed the Food and Drug Administration's New Dietary Ingredient (NDI) notification process, a complex pre-market evaluation procedure.

About Ajinomoto Co.

Founded in Japan in 1909, Ajinomoto Co. is a leader in the development of pharmaceutical-quality amino acids and safe, effective nutraceutical solutions to help people manage their weight, improve sleep quality and maintain healthy blood pressure levels already within the normal range*, delivering products backed by rigorous clinical studies.  For more information and a complete list of healthcare professionals that carry Ajinomoto Co.'s nutraceuticals, visit www.capsiatenatura.com, www.glysom.com and www.naturaguardbp.com

Capsiate Natura® clinical studies and White Paper available on request.

*These statements have not been evaluated by the Food and Drug Administration.  This product is not intended to diagnose, treat, cure, or prevent any disease.


'/>"/>
SOURCE Ajinomoto Co.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM)
2. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
3. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
4. Cancer Pioneer Reaches Key Agreement on Colon Cancer Drug OncoVAX(R)
5. CureHIV Reaches Out to Bill and Melinda Gates to Fund LiSAVIOR
6. Genmab Reaches Milestone in Ofatumumab Collaboration
7. Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials
8. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
9. Catalyst Reaches Enrollment Target for its U.S. Phase II Cocaine Trial
10. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
11. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 ... the "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural ... Structural electronics involves electronic and/or ... protective structures, replacing dumb structures such as vehicle ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
Breaking Medicine News(10 mins):